H
Hans-Peter Lenhof
Researcher at Saarland University
Publications - 170
Citations - 6982
Hans-Peter Lenhof is an academic researcher from Saarland University. The author has contributed to research in topics: Cancer & Macromolecular docking. The author has an hindex of 44, co-authored 164 publications receiving 6046 citations. Previous affiliations of Hans-Peter Lenhof include Max Planck Society.
Papers
More filters
Posted ContentDOI
Machine learning to detect Alzheimer\'s disease from circulating non-coding RNAs
Nicole Ludwig,Tobias Fehlmann,Manfred Gogol,Walter Maetzler,Walter Maetzler,Walter Maetzler,Stephanie Deutscher,Simone Gurlit,Claudia Schulte,Claudia Schulte,Anna-Katharina von Thaler,Anna-Katharina von Thaler,Christian Deuschle,Christian Deuschle,Florian Metzger,Daniela Berg,Daniela Berg,Daniela Berg,Ulrike Suenkel,Ulrike Suenkel,Verena Keller,Christina Backes,Hans-Peter Lenhof,Eckart Meese,Andreas Keller +24 more
TL;DR: The data provide strong evidence for the relevance of circulating non-coding RNAs to detect Alzheimer’s from a blood sample.
Journal ArticleDOI
Genome wide expression profiling identifies specific deregulated pathways in meningioma
Andreas Keller,Nicole Ludwig,Christina Backes,Bernd F. M. Romeike,Nicole Comtesse,Wolfram Henn,Wolf-Ingo Steudel,Christian Mawrin,Christian Mawrin,Hans-Peter Lenhof,Eckart Meese +10 more
TL;DR: Extended expression profiling by a novel statistical gene set enrichment identified pathways that have previously not been associated with meningioma that were significantly deregulated biochemical pathways using Kyoto encyclopedia of genes and genomes and Transpath databases.
Journal ArticleDOI
miR-34a as hub of T cell regulation networks
Martin Hart,Barbara Walch-Rückheim,Lena Krammes,Tim Kehl,Stefanie Rheinheimer,Tanja Tänzer,Birgit Glombitza,Martina Sester,Hans-Peter Lenhof,Andreas Keller,Eckart Meese +10 more
TL;DR: By simultaneous targeting of 14 mRNAs miR-34a acts as major hub of T cell regulatory networks suggesting to utilize miR -34a as target of intervention towards a modulation of the immune responsiveness of T-cells in a broad tumor context.
Journal ArticleDOI
Low miR-150-5p and miR-320b Expression Predicts Reduced Survival of COPD Patients
Andreas Keller,Andreas Keller,Nicole Ludwig,Tobias Fehlmann,Mustafa Kahraman,Christina Backes,Fabian Kern,Claus Vogelmeier,Caroline Diener,Ulrike Fischer,Frank Biertz,Christian Herr,Rudolf A. Jörres,Hans-Peter Lenhof,Robert Bals,Eckart Meese +15 more
TL;DR: Molecular profiles measured at the time of a COPD diagnosis have a high predictive power for the survival of patients and the abundance of the oncogenic miR-150-5p in blood of COPD patients was predictive for the development of cancer.
Journal ArticleDOI
Systematic permutation testing in GWAS pathway analyses: identification of genetic networks in dilated cardiomyopathy and ulcerative colitis
Christina Backes,Frank Rühle,Monika Stoll,Jan Haas,Karen S. Frese,Andre Franke,Wolfgang Lieb,Heinz-Erich Wichmann,Tanja Weis,Wanda Kloos,Hans-Peter Lenhof,Eckart Meese,Hugo A. Katus,Benjamin Meder,Andreas Keller +14 more
TL;DR: This study systematically investigated the impact of three different permutation test approaches for over-representation analysis to detect false positive pathway candidates and evaluated them on genome-wide association data of Dilated Cardiomyopathy and Ulcerative Colitis to provide evidence that the gold standard - permuting the case–control status – effectively improves specificity of GWAS pathway analysis.